After 13 years of mission and seven successive leaders, the UN at an impasse in Libya
Germany: search of AfD headquarters in Lower Saxony, amid accusations of embezzlement
Faced with Iran, Israel plays appeasement and continues its shadow war
Iran-Israel conflict: what we know about the events of the night after the explosions in Isfahan
“Even morphine doesn’t work”: Léane, 17, victim of the adverse effects of an antibiotic
Sánchez condemns Iran's attack on Israel and calls for "containment" to avoid an escalation
China's GDP grows 5.3% in the first quarter, more than expected
Alert on the return of whooping cough, a dangerous respiratory infection for babies
Vacation departures and returns: with the first crossovers, heavy traffic is expected this weekend
“Têtu”, “Ideat”, “The Good Life”… The magazines of the I/O Media group resold to several buyers
The A13 motorway closed in both directions for an “indefinite period” between Paris and Normandy
The commitment to reduce taxes of 2 billion euros for households “will be kept”, assures Gabriel Attal
The exclusive Vespa that pays tribute to 140 years of Piaggio
Kingdom of the great maxi scooters: few and Kymco wants the crown of the Yamaha TMax
A complaint filed against Kanye West, accused of hitting an individual who had just attacked his wife
In Béarn, a call for donations to renovate the house of Henri IV's mother
Skoda Kodiaq 2024: a 'beast' plug-in hybrid SUV
Tesla launches a new Model Y with 600 km of autonomy at a "more accessible price"
The 10 best-selling cars in March 2024 in Spain: sales fall due to Easter
A private jet company buys more than 100 flying cars
This is how housing prices have changed in Spain in the last decade
The home mortgage firm drops 10% in January and interest soars to 3.46%
The jewel of the Rocío de Nagüeles urbanization: a dream villa in Marbella
Rental prices grow by 7.3% in February: where does it go up and where does it go down?
With the promise of a “real burst of authority”, Gabriel Attal provokes the ire of the opposition
Europeans: the schedule of debates to follow between now and June 9
Europeans: “In France, there is a left and there is a right,” assures Bellamy
During the night of the economy, the right points out the budgetary flaws of the macronie
These French cities that will boycott the World Cup in Qatar
Formula 1: Verstappen wins the sprint in China, Hamilton 2nd
Rally: Neuville and Evans neck and neck after the first day in Croatia
Gymnastics: after Rio and Tokyo, Frenchman Samir Aït Saïd qualified for the Paris 2024 Olympics
Top 14: in the fight for maintenance, Perpignan has the wind at its back
Even in the worst crises, there is a need for medicine, and it has Novo Nordisk benefited in the first six months.
In the period have a larger sales have been to increase the surplus for the Danish medicinalgigant. It shows the half yearly financial information from the company.
Overall, Novo Nordisk is in the first six months of earned 22.5 billion dollars. This is an increase of 12 percent compared to the same period the year before.
Behind the increased profits is a turnover, which compared to the first half of last year has increased by eight percent to 63,9 billion dollars.
Novo Nordisk explains itself, that the sales growth in the first half of the year have been positively affected by customers ' stock-building, which has been related to coronaudbruddet.
It is, however, mainly in the first quarter that customers have really bought in to their store. In the second quarter, the customers have again reduced the stocks.
Common to the first and second quarter is that fewer patients according to Novo Nordisk has started the new treatment. It has kept the sales growth returned for the first half of the year.
Regardless of is management satisfied with the economic development that has been in the first six months.
Despite covid-19 is satisfied with the results in the first half of 2020, and with the progress we have made in our strategic ambitions, " says Lars Fruergaard Jørgensen, executive director at Novo Nordisk, in a comment.
The largest business area in Novo Nordisk is the development of agents for the treatment of diabetes. With more than 90 years of experience, the company is today one of the largest players in the field of diabetes treatment.
According to Søren Løntoft Hansen, analyst in Sydbank, facing Novo Nordisk with the best products on the market for diabetes treatment. It is the reason that the company continues to sell as much as it does.
- The product portfolio, such as Novo Nordisk has, in my assessment, also contribute to growth in the coming years, says Søren Løntoft Hansen.
It is particularly in the UNITED states, Novo Nordisk has a large sale of its products. Here, in the first half of the year alone has been sold for 27.8 billion dollars.
It is almost half of the company's total revenue of 63.9 billion.
